PLA2G7 and coronary artery disorder: Our study discovered that puerarin administration reduced serum lipoprotein-associated phospholipase 2 (Lp-PLA2) levels and improved lipid metabolism in elderly patients with CHD, while another study found that short-term puerarin supplementation did not improve lipid profiles in healthy Chinese men [19].